We are analyzing https://link.springer.com/article/10.1007/s11154-007-9033-5.

Title:
Growth factor signalling in endocrine and anti-growth factor resistant breast cancer | Reviews in Endocrine and Metabolic Disorders
Description:
Growth factors provide powerful mitogenic and survival signals to breast cancer cells and it is therefore not surprising that they are able to subvert inhibitory responses to anti-hormonal drugs. In this review we discuss several mechanisms by which this may be achieved and expand our observations to encompass recently emerging anti-growth factor treatments. The information presented is underpinned by inhibitor studies that show the targeting of such mechanisms in advance of anti-hormone or anti-growth factor resistance development is able to substantially delay this event, thus pointing the way forward to intelligent combination therapies relevant to the future management of breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,542,081 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, google, scholar, breast, cas, pubmed, growth, factor, receptor, cells, res, nicholson, gee, resistance, cell, epidermal, human, biol, barrow, hutcheson, endocr, endocrine, signalling, estrogen, oestrogen, tamoxifen, article, treat, mcf, tamoxifenresistant, kinase, insulinlike, jones, robertson, relat, mol, hiscox, knowlden, expression, chem, activity, phosphorylation, mcclelland, gefitinib, ici, inhibition, protein, activation, jmw, signaling,

Topics {✒️}

pcip/actr/aib-1/rac-3/tram-1 nf-kappab/ikappab signaling system anti-growth factor treatments mitogen-activated protein kinase estrogen-receptor-positive breast cancer growth factor cross-talk multi-functional pro-survival molecule anti-growth factor therapies phosphatidylinositol 3-kinase/akt-mediated activation er/her2-positive breast cancer tamoxifen-resistant mcf-7 cells tamoxifen-resistant tumorigenic growth hormone-independent tumor growth month download article/chapter antiestrogen-resistant breast cancer long-term oestrogen deprivation anti-hormone induced genes tamoxifen-resistant breast cancer improves anti-hormone response dual eerbb1/erbb2 inhibitor growth factors signal c-src-mediated phosphorylation endocrine-resistant breast cancer anti-hormonal therapy growth factor signalling estrogen-dependent gene expression endocrine therapy—current benefits enhanced anti-proliferative activity oestrogen receptor-mediated modulation ligand-bound oestrogen receptor anti-hormonal drugs growth factor receptor growth factor-1 receptor mcf-7 cells transfected growth factor signaling bidirectional cross talk tyrosine kinase inhibitors human cancer cells oestrogen-receptor positive human breast cancer c-met receptor phosphoinositide 3-kinase signalling long-term culture fibroblast growth factor mapk induces loss mcf-7 cells overexpressing steroid hormone receptors breast cancer growth nuclear factor-kappab mammary tumor cells

Questions {❓}

Selection of primary breast cancer patients for adjuvant endocrine therapy—is oestrogen receptor alone adequate?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Growth factor signalling in endocrine and anti-growth factor resistant breast cancer
         description:Growth factors provide powerful mitogenic and survival signals to breast cancer cells and it is therefore not surprising that they are able to subvert inhibitory responses to anti-hormonal drugs. In this review we discuss several mechanisms by which this may be achieved and expand our observations to encompass recently emerging anti-growth factor treatments. The information presented is underpinned by inhibitor studies that show the targeting of such mechanisms in advance of anti-hormone or anti-growth factor resistance development is able to substantially delay this event, thus pointing the way forward to intelligent combination therapies relevant to the future management of breast cancer.
         datePublished:2007-05-08T00:00:00Z
         dateModified:2007-05-08T00:00:00Z
         pageStart:241
         pageEnd:253
         sameAs:https://doi.org/10.1007/s11154-007-9033-5
         keywords:
            Breast cancer
            Anti-growth factor treatments
            Endocrine resistance
            Antihormones
            Endocrinology
            Diabetes
            Internal Medicine
         image:
         isPartOf:
            name:Reviews in Endocrine and Metabolic Disorders
            issn:
               1573-2606
               1389-9155
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:R. I. Nicholson
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:I. R. Hutcheson
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. E. Jones
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. E. Hiscox
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Giles
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. M. Taylor
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. M. W. Gee
               affiliation:
                     name:Cardiff University
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Growth factor signalling in endocrine and anti-growth factor resistant breast cancer
      description:Growth factors provide powerful mitogenic and survival signals to breast cancer cells and it is therefore not surprising that they are able to subvert inhibitory responses to anti-hormonal drugs. In this review we discuss several mechanisms by which this may be achieved and expand our observations to encompass recently emerging anti-growth factor treatments. The information presented is underpinned by inhibitor studies that show the targeting of such mechanisms in advance of anti-hormone or anti-growth factor resistance development is able to substantially delay this event, thus pointing the way forward to intelligent combination therapies relevant to the future management of breast cancer.
      datePublished:2007-05-08T00:00:00Z
      dateModified:2007-05-08T00:00:00Z
      pageStart:241
      pageEnd:253
      sameAs:https://doi.org/10.1007/s11154-007-9033-5
      keywords:
         Breast cancer
         Anti-growth factor treatments
         Endocrine resistance
         Antihormones
         Endocrinology
         Diabetes
         Internal Medicine
      image:
      isPartOf:
         name:Reviews in Endocrine and Metabolic Disorders
         issn:
            1573-2606
            1389-9155
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:R. I. Nicholson
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:I. R. Hutcheson
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. E. Jones
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. E. Hiscox
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Giles
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. M. Taylor
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. M. W. Gee
            affiliation:
                  name:Cardiff University
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Reviews in Endocrine and Metabolic Disorders
      issn:
         1573-2606
         1389-9155
      volumeNumber:8
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
      name:Cardiff University
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:R. I. Nicholson
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:I. R. Hutcheson
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:H. E. Jones
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:S. E. Hiscox
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:M. Giles
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:K. M. Taylor
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:J. M. W. Gee
      affiliation:
            name:Cardiff University
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(261)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.93s.

LINK . SPRINGER . COM {}